Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers

Journal of the American College of Cardiology

Volumn 43, Issue 2, 2004, Pages 224-233

  Hasegawa, Shinji ^a   Kusuoka, Hideo ^b   Maruyama, Kaoru ^a   Nishimura, Tsunehiko ^c   Hori, Masatsugu ^a   Hatazawa, Jun ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METOPROLOL; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONCENTRATION RESPONSE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DRUG EFFICACY; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; GLUCOSE TOLERANCE TEST; HEART FUNCTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART MUSCLE PERFUSION; HEMODYNAMIC MONITORING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; METHODOLOGY; PREDICTION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SCINTISCANNING; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 1042299090     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.09.025     Document Type: Article

References (25)

1. Neglia D, Sambuceti G, Iozzo P, L'Abbate, Strauss HW. Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy. Eur J Nucl Med 2002;29:1403-13.
2. Tillisch J., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
3. Maes A., Flameng W., Nuyts J., et al. Histological alterations in chronically hypoperfused myocardium - correlation with PET findings. Circulation. 90:1994;735-745.
4. Uehara T., Ishida Y., Hayashida K., et al. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy assessment by F-18-FDG PET study . Ann Nucl Med. 12:1998;95-103.
5. 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy. Ann Nucl Med. 14:2000;33-38.
6. Yokoyama I., Momomura S., Ohtake T., et al. Role of positron emission tomography using fluorine-18 fluoro-2-deoxyglucose in predicting improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy. Eur J Nucl Med. 25:1998;736-743.
7. Foody J.M., Farrell M.H., Krumholz H.M. β-Blocker therapy in heart failure. JAMA. 287:2002;883-889.
8. Yamada T., Fukunami M., Ohmori M., et al. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint. J Am Coll Cardiol. 21:1993;628-633.
9. Hirose M. Evaluation of left ventricular function and prognosis in patients with idiopathic cardiomyopathy in comparison with endomyocardial biopsy findings with semiquantitative histopathological analysis - comparative study of hypertrophic and congestive (dilated) cadiomyopathy. J Tokyo Wom Med Coll. 52:1982;292-306. (in Japanese).
10. Hasegawa S., Kusuoka H., Uehara T., Yamaguchi H., Hori M., Nishimura T. Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients. Ann Nucl Med. 12:1998;363-368.
11. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determinations echocardiographic-angiographic correlations in the presence or absence of asynergy . Am J Cardiol. 37:1976;7-11.
12. Stanek B., Frey B., Hulsmann M., et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 38:2001;436-442.
13. Fukuoka S., Hayashida K., Hirose Y., et al. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of beta-blocker therapy in patients with dilated cardiomyopathy. Eur J Nucl Med. 24:1997;523-529.
14. Yoshinaga K., Tahara M., Torii H., Kihara K. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy. Ann Nucl Med. 12:1998;341-347.
15. Tamai J., Nagata S., Nishimura T., et al. Hemodynamic and prognostic value of thallium-201 myocardial imaging in patients with dilated cardiomyopathy. Int J Cardiol. 24:1989;219-224.
16. Watanabe M., Gotoh K., Nagashima K., et al. Relationship between thallium-201 myocardial SPECT and findings of endomyocardial biopsy specimens in dilated cardiomyopathy. Ann Nucl Med. 15:2001;13-19.
17. Swan J.W., Anker S.D., Walton C., et al. Insulin resistance in chronic heart failure relation to severity and etiology of heart failure . J Am Coll Cardiol. 30:1997;527-532.
18. Wallhaus T.R., Taylor M., DeGrado T.R., et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation. 103:2001;2441-2446.
19. van den Heuvel A.F.M., van Veldhuisen D.J., van der Wall E.E., et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 35:2000;19-28.
20. Billingham ME. Role of endomyocardial biopsy in diagnosis and treatment of heart disease. In: Silver MD, editor. Cardiovascular Pathology. 2nd ed. New York, NY: Churchill Livingstone, 1991;1465-86.
21. 18F]fluoro- 6-thia-heptadecanoic acid. J Nucl Med. 42:2001;55-62.
22. Kelly D.P., Gordon J.I., Alpers R., Strauss A.W. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase . J Biol Chem. 264:1989;18921-18925.
23. Batista R.J., Verde J., Nery P., et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg. 64:1997;634-638.
24. 18F-2-deoxyglucose uptake in pigs with hibernating myocardium. Circulation. 102:2000;908-914.
25. Hasumi M., Sekiguchi M., Yu Z.X., Hirosawa K., Hiroe M. Analysis of histopathologic findings in cases with dilated cardiomyopathy with special reference to formulating diagnostic criteria on the possibility of postmyocarditic change. Jpn Circ J. 50:1986;1280-1287.